B.

Drug Study DRUG NAME DRUG CLASS DOSE/TIMING/ROUTE INDICATIONS Replacement and Zinc Sulfate (E-Zinc drops) 1-29-12 Pharmacologic: Trace minerals Therapeutic: Mineral and electrolyte replacements/supplements 1 mL OD PO supplementation therapy in patients who are at risk for zinc deficiency, including patients on long-term parenteral nutrition. MECHANISM OF ACTION Serves as a cofactor for many enzymatic reactions. Required for normal growth and tissue repair, wound healing, and senses of taste and smell. ADVERSE / SIDE EFFECTS gastric irritation nausea vomiting NURSING RESPONSIBILITIES Monitor progression of zinc deficiency symptoms (impaired wound healing, growth retardation, decreased sense of taste, decreased sense of smell) during therapy.

DRUG NAME

DRUG CLASS

DOSE/TIMING/ROUTE

INDICATIONS anxiety

MECHANISM OF ACTION Acts as an CNS depressant at the subcortical level of the CNS. Has anticholinergic, antihistamitic, and antiemetic properties. Blocks histamine 1 receptors.

ADVERSE / SIDE EFFECTS drowsiness dizziness headache dry mouth constipation nausea and vomiting

NURSING RESPONSIBILITIES Assess patient for profound sedation and provide safety precautions as indicated ( side rails up, bed in low position, supervision of ambulation and transfer). Anxiety: Assess mental status Nausea and Vomiting: Assess degree of nausea and frequency and amount of emesis.

Hydroxyzine (Iserax) 1-31-12

Therapeutic: Antianxiety agents, antihistamines, sedative/hypnotics

2 mL TID PO

preoperative sedation antiemetic antipruritic

DRUG NAME

DRUG CLASS

DOSE/TIMING/ROUTE

INDICATIONS mild pain

MECHANISM OF ACTION Inhibits the synthesis of prostaglandins that may serve as mediators of pain and fever, primarily in the CNS. Has no significant antiinflamatory properties or GI toxicity.

ADVERSE / SIDE EFFECTS hepatic failure heaptic toxicity renal failure neutropenia pancytopenia leukopenia rash urticaria

NURSING RESPONSIBILITIES Assess overall health status. Patients who are malnourished are at risk or chronically abuse alcohol is at higher risk of developing hepatoxicity with chronic use of usual doses of this drug. Fever: Assess fever; note presence of associated signs (diaphoresis, tachycardia, and malaise). If overdose occurs, acetylcystein is the antidote.

Paracetamol (Tempra drops) 1-29-12

Therapeutic: Antipyretics, nonopoid analgesics

1.3 mL - q4 PO - prn

fever